Stay updated on Tislelizumab After Liver-Directed Therapy Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.

Latest updates to the Tislelizumab After Liver-Directed Therapy Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has undergone significant changes, including the addition of specific drug information for Tislelizumab and the facility's name and location, while also removing previous location details and drug classifications.SummaryDifference2%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to Tislelizumab After Liver-Directed Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.